BA
MRNA icon

Bellwether Advisors’s Moderna MRNA Stock Holding History

Bellwether Advisors’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-16,820
Closed -$2.58M – 310
2023
Q1 		$2.58M Buy
16,820
+16,720
+16,720% +$2.76M 0.71% 28
2022
Q4 		$18K Hold
100
– – 0.01% 246
2022
Q3 		$11K Hold
100
– – ﹤0.01% 256
2022
Q2 		$14K Sell
100
-10
-9% -$1.43K ﹤0.01% 233
2022
Q1 		$18K Hold
110
– – 0.01% 267
2021
Q4 		$27K Sell
110
-2,813
-96% -$822K 0.01% 248
2021
Q3 		$1.12M Buy
2,923
+2,823
+2,823% +$1.04M 0.37% 54
2021
Q2 		$23K Buy
+100
New +$17.9K 0.01% 214

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bellwether Advisors's MRNA Position: Q2 2023 in Review

Bellwether Advisors sold out of Moderna (MRNA) in Q2 2023, closing a stake of 16,820 shares — an estimated $2.58M sold.

Bellwether Advisors first reported a position in MRNA in Q2 2021 and held it in 8 quarters. The position peaked at $2.58M in Q1 2023. 965 funds tracked by Wall St. Rank hold MRNA as of Q2 2023.

  • Bellwether Advisors reported no remaining Moderna position as of Q2 2023 after selling out during the quarter.
  • Bellwether Advisors sold 16,820 Moderna shares in Q2 2023, an estimated $2.58M.
  • Bellwether Advisors first reported a position in Moderna in Q2 2021 and held it in 8 quarters.
  • Bellwether Advisors's Moderna position peaked at $2.58M in Q1 2023.
  • 965 funds tracked by Wall St. Rank held Moderna as of Q2 2023.

Based on Bellwether Advisors's 13F filing for Q2 2023, filed 4 Aug 2023.